EORTC-22114-40111-GITCG-ROG

Back to Clinical Trials Database

Trial of preoperative therapy for gastric and esophagogastric junction adenocarcinoma. A randomized phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.

Study documentation Publications

Trial Status	Recruiting
Dates	Date of activation: 13-Nov-2013
Data management at EORTC	No
Design	Phase 2-3 Randomized open label
Targeted Sample size	EORTC Groups: 211 - All Groups: 570
Treatment	Radiotherapy
Study Staff	Karin Haustermans (Study Coordinator) , U.Z. Leuven - Campus Gasthuisberg, Leuven Florian Lordick (Study Coordinator) , Universitaetsklinikum Leipzig UCCL-Krebszentrum, Leipzig Kin Jip Cheung (Senior Clinical Operations Manager) kin-jip.cheung (at) eortc.org, EORTC Headquarters, Brussels Catherine Fortpied (Statistician) catherine.fortpied (at) eortc.org, EORTC Headquarters, Brussels Beatrice Fournier (Clinical Scientist) beatrice.fournier (at) eortc.org, EORTC Headquarters, Brussels Julie Hermans (Regulatory Affairs Manager) julie.hermans (at) eortc.org, EORTC Headquarters, Brussels Axelle Nzokirantevye (Data Manager) axelle.nzokirantevye (at) eortc.org, EORTC Headquarters, Brussels Laurens Vinckier (Pharmacovigilance Manager) laurens.vinckier (at) eortc.org, EORTC Headquarters, Brussels
Type of cancer	Gastric
Participating groups	EORTC Gastrointestinal Tract Cancer Group EORTC Radiation Oncology Group Australasian Gastro-Intestinal Trials Group Trans-Tasman Radiation Oncology Group Inc
Recruiting centers	AZ Turnhout - Campus Sint Elisabeth (Turnhout, Belgium) Asklepios Tumorzentrum Hamburg AK Barmbek (Hamburg, Germany) CHRU de Besancon - Hopital Jean Minjoz (Besancon, France) Centre Hospitalier Regional Verviers (East Belgium) (Verviers, Belgium) Hopital De Jolimont (Haine St Paul, Belgium) Hopital Nord Franche-Comte - Site du Mittan (Montbeliard, France) Hospital Clinico Universitario De Valencia (Valencia, Spain) Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain) ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain) ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain) Institut Sainte Catherine (Avignon, France) Institut de Cancerologie Strasbourg Europe (formar Paul Strauss) (Strasbourg, France) Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany) Onkologie UnterEms, Leer-Papenburg-Emden (Leer, Germany) Rambam Health Care Campus, Oncology Institute (Haifa, Israel) Staedtisches Klinikum Braunschweig gGmbH (Braunschweig, Germany) The Institute Of Oncology (Ljubljana, Slovenia) U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) Univ. Rostock - Campus Schilingallee (Rostock, Germany) Universitaetsklinikum Leipzig UCCL-Krebszentrum (Leipzig, Germany) Universitaetsklinikum Tuebingen- Crona Kliniken (Tuebingen, Germany) Universitair Ziekenhuis Antwerpen (Edegem, Belgium) University Hospital Hradec Kralove (Hradec Kralove, Czech Republic)
Centers to be activated	Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere (Paris, France) Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Roma, Italy) Hopital De Jolimont (Haine St Paul, Belgium) Hospital Clinico Universitario De Valencia (Valencia, Spain) Univ. Rostock-Zentrum fur Radiologie mit Klinik und Poliklinik fur Strahlentherapie (Rostock, Germany)
Protocol summary	http://clinicaltrials.gov/ct/show/NCT01924819
NCT number	NCT01924819